Can losartan be co-administered with Paxlovid (nirmatrelvir/ritonavir)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Losartan and Paxlovid Be Taken Together?

Yes, losartan can be safely co-administered with Paxlovid (nirmatrelvir/ritonavir) without dose adjustment or interruption. Losartan does not have clinically significant drug-drug interactions with the ritonavir component of Paxlovid.

Understanding the Drug Interaction Risk

The primary concern with Paxlovid is the ritonavir component, which acts as a strong CYP3A4 inhibitor 1. The FDA label explicitly warns about potentially severe, life-threatening, or fatal drug interactions with medications metabolized through this pathway 2. However, losartan's metabolism does not create a problematic interaction:

  • Losartan is primarily metabolized by CYP2C9, not CYP3A4
  • While ritonavir does inhibit CYP3A4, CYP2D6, and P-glycoprotein 3, these pathways are not the primary routes for losartan metabolism
  • Losartan does not appear on lists of contraindicated or problematic medications requiring dose adjustment with Paxlovid

Clinical Management Algorithm

For patients currently taking losartan who need Paxlovid:

  1. Continue losartan at the current dose - no adjustment needed
  2. Initiate Paxlovid as indicated: 300 mg nirmatrelvir with 100 mg ritonavir twice daily for 5 days 2, 4
  3. Monitor blood pressure routinely, as you would normally
  4. No interruption of losartan is required during the 5-day Paxlovid course

Important Caveats for Other Medications

While losartan is safe, the broader context matters. Guidelines emphasize that prior to prescribing Paxlovid, you must review ALL medications the patient takes 2. Among commonly prescribed drugs:

  • 56% have no interaction with Paxlovid
  • 30% have potential interactions requiring management
  • 14% require specific evaluation 5

High-risk medication classes that DO require intervention include:

  • Statins (especially atorvastatin - requires dose reduction) 6
  • Immunosuppressants like tacrolimus (requires interruption and close monitoring) 7
  • Certain antiarrhythmics, sedatives, and anticoagulants 8, 9

Practical Considerations

The Liverpool COVID-19 Drug Interaction Tool is specifically recommended by WHO guidelines as an open repository for checking interactions 1. Use this resource when prescribing Paxlovid to any patient on multiple medications.

Renal function matters for Paxlovid dosing (though not specifically for the losartan interaction):

  • Normal/mild impairment (eGFR ≥60): standard dose
  • Moderate impairment (eGFR 30-59): reduce to 150 mg nirmatrelvir with 100 mg ritonavir twice daily 2, 4
  • Severe impairment (eGFR <30): Paxlovid not recommended 2

The evidence strongly supports Paxlovid's effectiveness in reducing hospitalization by 39% and death by 61% in real-world settings 10, making it critical to prescribe when indicated - and the absence of interaction with losartan removes one barrier to its use in hypertensive patients with COVID-19.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.